Morgan Stanley Call 42.5 OMV 20.1.../ DE000MG5TTW0 /
05/08/2024 20:03:42 | Chg.- | Bid10:09:37 | Ask10:09:37 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.100EUR | - | 0.101 Bid Size: 25,000 |
0.110 Ask Size: 25,000 |
OMV AG | 42.50 EUR | 20/12/2024 | Call |
GlobeNewswire
26/03
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
16/01
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
14/09/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
13/10/2021
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center